Hu H - Search Results

1

Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence - A retrospective single-center study.

Deng Y, Cai Y, Lin J, Jiang L, Hu H. Deng Y, et al. Among authors: hu h. Gastroenterol Rep (Oxf). 2015 Nov;3(4):339-43. doi: 10.1093/gastro/gov051. Epub 2015 Oct 13. Gastroenterol Rep (Oxf). 2015. PMID: 26468218 Free PMC article.

2

Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis.

Hu H, Xie Y, Yang G, Jian C, Deng Y. Hu H, et al. Eur J Cancer Prev. 2014 Jan;23(1):62-8. doi: 10.1097/CEJ.0b013e328360f479. Eur J Cancer Prev. 2014. PMID: 23549150

3

Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis.

Yang G, Hu H, Zeng R, Huang J. Yang G, et al. Among authors: hu h. J Clin Gastroenterol. 2013 Oct;47(9):741-8. doi: 10.1097/MCG.0b013e31829e446b. J Clin Gastroenterol. 2013. PMID: 24030705

4

[Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience].

Cai Y, Hu H, Wang W, Cao T, Deng Y. Cai Y, et al. Among authors: hu h. Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Nov;17(11):1081-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2014. PMID: 25421765 Chinese.

5

Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies.

Hu H, Cai Y, Huang J, Zhang J, Deng Y. Hu H, et al. Eur J Cancer Prev. 2015 Nov;24(6):462-9. doi: 10.1097/CEJ.0000000000000113. Eur J Cancer Prev. 2015. PMID: 25494291

6

Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study.

Zhang J, Cai Y, Hu H, Lan P, Wang L, Huang M, Kang L, Wu X, Wang H, Ling J, Xiao J, Wang J, Deng Y. Zhang J, et al. Among authors: hu h. Oncotarget. 2016 Jan 26;7(4):5053-62. doi: 10.18632/oncotarget.6469. Oncotarget. 2016. PMID: 26646794 Free PMC article.

7

Application and comparison of different implanted ports in malignant tumor patients.

Li Y, Cai Y, Gan X, Ye X, Ling J, Kang L, Ye J, Zhang X, Zhang J, Cai Y, Hu H, Huang M, Deng Y. Li Y, et al. Among authors: hu h. World J Surg Oncol. 2016 Sep 23;14(1):251. doi: 10.1186/s12957-016-1002-6. World J Surg Oncol. 2016. PMID: 27664131 Free PMC article.

8

[Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].

Cai Y, Deng R, Hu H, Zhang J, Ling J, Wu Z, Yang L, Li J, Deng Y. Cai Y, et al. Among authors: hu h. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1045-1050. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30269326 Chinese.

9

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.

Hu H, Huang J, Lan P, Wang L, Huang M, Wang J, Deng Y. Hu H, et al. BMC Cancer. 2018 Nov 20;18(1):1145. doi: 10.1186/s12885-018-4997-y. BMC Cancer. 2018. PMID: 30458734 Free PMC article. Clinical Trial.

10

Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.

Zhang J, Huang M, Cai Y, Wang L, Xiao J, Lan P, Hu H, Wu X, Ling J, Peng J, Chen D, Kang L, Zhang Y, Ren D, Wang H, Chen S, Lin F, Zheng J, Zhou Z, Wang J, Deng Y. Zhang J, et al. Among authors: hu h. Clin Colorectal Cancer. 2019 Dec;18(4):238-244. doi: 10.1016/j.clcc.2019.07.001. Epub 2019 Jul 11. Clin Colorectal Cancer. 2019. PMID: 31378655 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,008 results

Search Page

Filters